Oncology

San Diego
#AACR #Cancer research #Events #Oncology

News from AACR 2024: Tuesday’s highlights

Today, National Cancer Institute leaders discussed cancer breakthroughs and the importance of securing support from lawmakers for the NCI and National Institutes of Health in the session ‘The Cancer Moonshot: Opportunities to Fulfill the Vision of the National Cancer Plan – Dedicated to the Memory of Sen. Dianne… Read More

#Cancer Research #News #Trending News

San Diego
#AACR #Cancer research #Events #Oncology

News from AACR 2024: Monday’s highlights

A round-up of the latest news from the American Association of Cancer Research (AACR) Annual Meeting. Symposiums UCLA: Dr Zev Wainberg, Co-Director of the UCLA Health GI Oncology Program, presented results from pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators, which suggests that for… Read More

#Cancer Research #News #Trending News

#Lung cancer #Non-small cell lung cancer (NSCLC) #Oncology #University of California

Genetically engineered dendritic cells enhance lung cancer therapy

A study by researchers at the UCLA Health Jonsson Comprehensive Cancer Center in the US suggests that injecting engineered dendritic cells directly into cancerous lung tumours can help promote a stronger immune response. When tested in mice with non-small cell lung cancer (NSCLC), the team discovered… Read More

#Cancer Research #News

San Diego
#AACR #Cancer research #Events #Oncology

News from AACR 2024: Sunday’s highlights

The American Association of Cancer Research (AACR) Annual Meeting launched on Sunday 7 April in San Diego with an Opening Plenary Session showcasing cutting-edge technological advances opening new frontiers in cancer science. The session ‘Inspiring Science, Fueling Progress, Revolutionizing Care’ featured a distinguished panel of cancer… Read More

#Cancer Research #News #Trending News

Cancer cells
#Breast cancer #Cancer research #CAR-T #Cell therapy #Oncology

eBook: Breakthroughs in oncology research and drug discovery

While the age-adjusted overall cancer death rate in the US fell by 33% between 1991 and 2020, cancer remains a significant threat to human health, with more than two million new cases expected to be diagnosed in 2024 and uneven progress across different cancer types1. These… Read More

#News

Japanese flag
#Astellas Pharma #Gastrointestinal #Japan #Monoclonal antibodies #Oncology

Japan becomes first country to approve Astellas’ gastric cancer mAb

Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Vyloy (zolbetuximab), an anti-claudin 18.2 (CLDN18.2) monoclonal antibody for patients with CLDN18.2 positive, unresectable, advanced or recurrent gastric cancer. Vyloy is the first and only CLDN18.2-targeted therapy approved by any regulatory agency in the world. Read More

#News #Regulatory

#Cancer research #Drug discovery #eBook #Oncology

Breakthroughs in oncology research and drug discovery

This 24-page eBook sponsored by Sino Biological explores the latest innovations in cancer therapeutics and where we can expect the greatest breakthroughs in the future. Download this exclusive eBook to learn more about: The opportunities and advances in cancer research Why liquid biopsies are important in precision medicine trials for… Read More

#DDW eBooks #Intelligence

Cancer cells
#Breast cancer #Drug targets #Epigenetics #Oncology #The Institute of Cancer Research

Research uncovers how to target dormant breast cancer cells

Scientists have discovered how breast cancer cells can ‘hibernate’ to avoid treatment and ‘wake up’ years later – causing a relapse that is more difficult to treat. Their research, published in the journal Cancer Discovery, reveals the role of epigenetics in controlling how cancer cells can… Read More

#Cancer Research #News

#Cancer research #In Focus Report #Market reporting #Oncology

DDW In Focus eReport: Oncology breakthroughs and innovation

Created by DDW and sponsored by HUB Organoids, ‘Oncology research: Where are the breakthroughs and innovation?’  is a free In Focus report now available to download. Oncology represents the drug discovery and development sector’s biggest focus area and whilst novel treatments continue to emerge… Read More

#News

#Cancer research #Drug discovery #In Focus Report #Oncology

Oncology Research: Where are the breakthroughs & innovation?

Download this exclusive DDW eReport to learn more about: Oncology drug discovery and development: A market overview The technologies and therapeutic approaches that will drive the future of cancer drug discovery Oncology, drug discovery and the potential of organoids The research driving advancements in oncology and recent approvals in the sector… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

#Antibodies #Cancer #Cancer research #Diagnostics #Drug discovery #Fibroblasts #Flow Cytometry #Immunology #Oncology #Tumour biology

Podcast: Flow cytometry for drug discovery research

This is the latest episode of the free DDW narrated podcast, titled “Flow cytometry for drug discovery research” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Flow cytometry technologies and cancer associated fibroblasts and Leveraging… Read More

#News

Image of the earth showing the UK and Scandinavia
#Cancer Research UK #Collaboration #Norwegian Cancer Society #Oncology

UK-Norway partnership to speed up cancer drug discovery

Cancer Research UK and the Norwegian Cancer Society (NCS) have announced a new multi-project strategic partnership to maximise the unique drug development capabilities of both countries. Under the partnership, NCS intends to share funding and expertise to accelerate the development of cancer drug candidates with the… Read More

#Cancer Research #News

CAR-T therapy
#Blood cancer #Bristol Myers Squibb #CAR-T #Cell therapy #FDA #Leukaemia #Oncology

FDA approves first CAR-T cell therapy for relapsed CLL or SLL

The US Food and Drug Administration (FDA) has granted accelerated approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for relapsed or refractory chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL). It is approved in adult patients who have… Read More

#News #Regulatory #Trending News

MRI showing glioblastoma
#Brain cancer #CAR-T #Cell therapy #Oncology #University of Pennsylvania

‘Dual-target’ CAR-T cell therapy shrinks brain tumours

Targeting two brain tumour-associated proteins – rather than one – with CAR-T cell therapy has shown promise as a strategy for reducing solid tumour growth in patients with recurrent glioblastoma (GBM). This is according to early results from the first six patients treated in an ongoing… Read More

#Cancer Research #News

Cancer cells
#Cancer drug targets #Francis Crick Institute #Oncology #Treatment resistance

Study identifies new targets for cancer therapy

Researchers at the Francis Crick Institute in the UK have shed light on how cancer cells survive after being cut off from oxygen, a finding that could help to prevent cancer from becoming resistant to treatment. When oxygen supplies are low, most cells change which proteins… Read More

#Cancer Research #Editor's Choice #News